AbbVie Stock Pulls Back After Six-Day Rally Runs Out of Steam
AbbVie shares snapped a six-session winning streak, signaling a potential short-term cooldown after a sustained bullish run.
AbbVie had a good run — six straight sessions of gains is nothing to scoff at. But every rally needs a breather, and the pharmaceutical giant's stock finally took one, slipping after that impressive winning streak came to an end.
For traders watching the tape, a six-session streak is a meaningful momentum signal. When that kind of run breaks, it often flushes out short-term momentum buyers and opens the door for a healthy consolidation before the next directional move. Whether this dip is a buying opportunity or the start of something uglier depends on what drove the rally in the first place.
Read more Owens Corning Gets Evercore Upgrade on Carlisle Buyout Buzz →
AbbVie remains a heavyweight in the pharma space, with its portfolio and pipeline carrying significant weight on investor sentiment. Any pullback in a name like this tends to attract attention from longer-term investors looking for a better entry point — but short-term traders need to respect the momentum shift until the chart proves otherwise.
The key now is whether AbbVie can hold key support levels and build a new base, or whether sellers pile in and erase more of those recent gains. Keep it on your watchlist — this one isn't done moving. Continue reading at SeekingAlpha.
